Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
ID
Koren, Ana
(
Author
),
ID
Rijavec, Matija
(
Author
),
ID
Krumpestar, Tomaž
(
Author
),
ID
Kern, Izidor
(
Author
),
ID
Sadikov, Aleksander
(
Author
),
ID
Čufer, Tanja
(
Author
),
ID
Korošec, Peter
(
Author
)
PDF - Presentation file,
Download
(754,45 KB)
MD5: C5CC7167711499EAC9EB7DF77EF5586E
URL - Source URL, Visit
https://www.mdpi.com/2072-6694/13/10/2309
Image galllery
Abstract
Background: Hypoxia correlates with poor prognosis in several cancer types, including lung cancer. Prolyl hydroxylase domain proteins (PHDs) play a role in cell oxygen sensing, negatively regulating the hypoxia-inducible factor (HIF) pathway. Our study aim was to evaluate PHD1, PHD2 and PHD3 mRNA expression levels in primary tumours and normal lungs of non-small-cell lung cancer (NSCLC) patients and to correlate it with selected regulators of HIF signalling, with clinicopathological characteristics and overall survival (OS). Methods: Tumour tissue samples were obtained from 60 patients with surgically resected NSCLC who were treated with radical surgery. In 22 out of 60 cases, matching morphologically normal lung tissue was obtained. PHD1, PHD2 and PHD3 mRNA expressions were measured using RT-qPCR. Results: The PHD1 and PHD2 mRNA levels in primary tumours were significantly decreased compared to those in normal lungs (both p < 0.0001). PHD1 and PHD2 expression in tumours was positively correlated (r$_s$ = 0.82; p < 0.0001) and correlated well with HIF pathway downstream genes HIF1A, PKM2 and PDK1. Decreased PHD1 and PHD2 were associated with larger tumour size, higher tumour stage (PHD1 only) and squamous cell carcinoma. Patients with low PHD1 and patients with low PHD2 expression had shorter OS than patients with high PHD1 (p = 0.02) and PHD2 expression (p = 0.01). PHD1 showed borderline independent prognostic values in multivariate analysis (p = 0.06). In contrast, we found no associations between PHD3 expression and any of the observed parameters. Conclusions: Our results show that reduced expression of PHD1 and PHD2 is associated with the development and progression of NSCLC. PHD1 could be further assessed as a prognostic marker in NSCLC.
Language:
English
Keywords:
non-small-cell lung cancer
,
mRNA expression
,
prolyl hydroxylase domain proteins
,
carcinoma
,
prognosis
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FRI - Faculty of Computer and Information Science
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
14 str.
Numbering:
Vol. 13, iss. 10, art. 2309
PID:
20.500.12556/RUL-135654
UDC:
616-006
ISSN on article:
2072-6694
DOI:
10.3390/cancers13102309
COBISS.SI-ID:
63269891
Publication date in RUL:
23.03.2022
Views:
1125
Downloads:
93
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Cancers
Shortened title:
Cancers
Publisher:
MDPI
ISSN:
2072-6694
COBISS.SI-ID:
517914137
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
12.05.2021
Secondary language
Language:
Slovenian
Keywords:
izražanje mRNA
,
beljakovine s prolil hidroksilazno domeno
,
nedrobnocelični karcinom pljuč
,
prognoza
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-7372
Name:
Molekularni označevalci raka pljuč in njim prilagojeno zdravljenje
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0360
Name:
Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back